5728-52-9
[1]CurrentPatentAssignee:AICURISGMBH&CO.KG-US2004/6076,2004,A1Locationinpatent:Page16
[1]CurrentPatentAssignee:AICURISGMBH&CO.KG-EP2573086,2013,A1Locationinpatent:Paragraph0071
[2]CurrentPatentAssignee:AICURISGMBH&CO.KG-WO2013/45479,2013,A1Locationinpatent:Page/Pagecolumn22
[3]CurrentPatentAssignee:AICURISGMBH&CO.KG-US2004/6076,2004,A1Locationinpatent:Page16-17
[4]Carta,Fabrizio;Birkmann,Alexander;Pfaff,Tamara;Buschmann,Helmut;Schwab,Wilfried;Zimmermann,Holger;Maresca,Alfonso;Supuran,ClaudiuT.[JournalofMedicinalChemistry,2017,vol.60,#7,p.3154-3164]
[5]CurrentPatentAssignee:AICURISGMBH&CO.KG-WO2018/96170,2018,A1Locationinpatent:Page/Pagecolumn41;42
[1]CurrentPatentAssignee:AICURISGMBH&CO.KG-EP2573086,2013,A1
[1]CurrentPatentAssignee:AICURISGMBH&CO.KG-EP2573086,2013,A1
[1]CurrentPatentAssignee:AICURISGMBH&CO.KG-EP2573086,2013,A1Locationinpatent:Paragraph0072
[2]CurrentPatentAssignee:AICURISGMBH&CO.KG-WO2013/45479,2013,A1Locationinpatent:Page/Pagecolumn22-23
Title: Baseline sensitivity of HSV-1 and HSV-2 clinical isolates and defined acyclovir-resistant strains to the helicase-primase inhibitor pritelivir.
Journal: Antiviral research 20131101
Title: ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Journal: The Journal of antimicrobial chemotherapy 20100801
Title: Efficacy of a helicase-primase inhibitor in animal models of ocular herpes simplex virus type 1 infection.
Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20080201
Title: Herpes simplex virus helicase-primase inhibitors: recent findings from the study of drug resistance mutations.
Journal: Antiviral chemistry & chemotherapy 20080101
Title: The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.
Journal: Antiviral research 20070701
Title: Superior efficacy of helicase-primase inhibitor BAY 57-1293 for herpes infection and latency in the guinea pig model of human genital herpes disease.
Journal: Antiviral chemistry & chemotherapy 20070101
Title: Antiviral therapies.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20040401
Title: Potent in vivo antiviral activity of the herpes simplex virus primase-helicase inhibitor BAY 57-1293.
Journal: Antimicrobial agents and chemotherapy 20020601
Title: New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.
Journal: Nature medicine 20020401
Title: Ligat G, et al. Identification of Amino Acids Essential for Viral Replication in the HCMV Helicase-PrimaseComplex. Front Microbiol. 2018 Oct 23;9:2483.
Title: Wald A, et al. Helicase-primase inhibitor Pritelivir for HSV-2 infection. N Engl J Med. 2014 Jan 16;370(3):201-10.
Title: Quenelle DC, et al. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis. Antiviral Res. 2018 Jan;149:1-6.
